ArticleFrontiers in pediatrics2025
3D-printed cranial helmet therapy for the treatment of deformational plagiocephaly.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Deformational Plagiocephaly (DP) is the most common cranial deformity in infants. It may be treated using molding cranial helmet therapy (CHT) or active counter-positioning (ACP). Molding CHT has proven to be highly effective, especially in moderate to severe cases. Although many studies have explored this topic, few have investigated the use of 3D-printed CHT. This method may offer greater accuracy and convenience in measurement compared to traditional helmet types. Furthermore, no studies on this subject have been conducted in the Middle East. Study design: A retrospective study design. Methods: Electronic medical records from the only medical center fitting infants with 3D-printed CHT were reviewed. Infants diagnosed with DP who were fitted with and completed treatment using 3D-printed CHT were included. Infants who received 3D-printed CHT for other cranial deformities were excluded. Descriptive statistics (mean ± SD) were used to present results related to Cranial Vault Asymmetry Index (CVAI) and participants' characteristics. A Linear Mixed Model was used to assess changes in CVAI over time, accounting for age, gender, and treatment duration. Model assumptions were tested, and findings were validated using a Wilcoxon signed-rank test. Results: Records of eleven infants diagnosed with DP were included, eight boys and three girls. A significant reduction in CVAI was reported in all cases. No significant correlation was found between CVAI improvement and gender, age, or treatment duration. Conclusion: Following treatment with customized 3D-printed CHT, infants in the study demonstrated significant improvement in the CVAI. The helmets effectively guided cranial growth toward the flattened area, aiding in the correction of the deformity. Although 3D-printed CHT showed results comparable to traditional molding CHT, it offers potential advantages such as increased measurement accuracy through 3D scanning, easier monitoring of progress, and reduced cost and time associated with fabrication through 3D printing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.